Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an
about
The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis.Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in miceKaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in SicilyExtracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsets.Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South AfricaImmunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramerAntitumour effects of antiretroviral therapy.Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated HerpesvirusKaposi's sarcoma and its associated herpesvirus.Professional antigen presenting cells in human herpesvirus 8 infection.The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.Transient expansion of activated CD8(+) T cells characterizes tuberculosis-associated immune reconstitution inflammatory syndrome in patients with HIV: a case control study.Liposomal daunorubicin as treatment for Kaposi's sarcomaKaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adultsDo we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Immunotherapy in Sarcoma: Future Horizons.Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation.The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus.Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cellsReconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.Viral coinfections among African children infected with human immunodeficiency virus type 1.Role of Pattern Recognition Receptors in KSHV Infection.
P2860
Q33470219-A01E43CD-FF3F-42C9-B340-84FB821071A9Q33610926-A7F3D995-4A14-4BB9-871C-FC503357BBD2Q34101588-741D7D45-C266-4807-8524-341A2339F3EDQ34103593-9582B65F-34A9-4E95-9C09-7D6F2459C202Q34189939-C6B3D51E-F85D-43D4-8F6A-127FBF03595EQ34587349-9A101074-D9F3-4428-BFF0-82F37D3BFC72Q34597442-C9D9AB2D-FF56-4161-8CBC-5A87EED5D03BQ34627126-BB12C4E3-B34A-47FB-B468-3FE5A29095F2Q34781748-AE82FC04-31E9-41D1-8320-DC2DA28DF4D2Q35026060-C6FB2009-FF0F-4CD5-8B72-3A11F9967C7BQ35249061-11DCE1BE-8875-4BDA-8A3C-75EF4B194AB6Q35453657-0FA355F2-A302-48C3-B9F0-64A38370EFE8Q35573825-2B8976A0-278D-4DD8-9959-78C6E5CC97B6Q35632074-AFC3D39C-DFDF-47AE-B1CD-9D840C26BD71Q35854117-E689C6AB-908C-4E4B-8129-81FCBD1C2571Q35857736-EF005CFA-AB15-4EC3-83EB-4C3711837E0BQ35934144-8AC3E9B8-332D-4F9E-AC71-28736F743950Q36145066-C0D250F3-CB2E-45C9-B433-234D7FD5A56BQ36487309-598FE657-726F-4478-87E3-110933F66047Q36546999-5198AFAF-94E6-4818-9446-65E0E5E54BB7Q36563576-0A1C1343-1903-44C3-89F3-D610A3CC8F49Q36921904-B98A7E9C-98E7-4A51-9B90-7F9FD2DF9C6BQ37004096-0834AD49-053F-4AFA-AD14-BA2FFC4B8332Q37015398-E08AA481-1861-4D4A-A455-39A51544EB97Q38081246-136D570E-05FB-4B1B-944D-BDD9448354EDQ38596093-A1344A28-CC67-4E88-802A-541A57110679Q39284842-019D5B2F-1854-47F0-AAA2-7D8F61CE365DQ39591598-7A717679-5A1D-4323-9DDC-B30B50325548Q40970345-7809E85D-0770-41A6-9561-281DE8E6042AQ41594489-B7E341A7-4D0D-4E05-AC6D-D8EEDF2C728DQ42446461-CBFE81A4-49B6-4C2D-B6FC-DA296B7661D7Q43049174-75EA685C-369A-4329-9853-09B9BE78B369Q55338587-680ECB5C-C89A-408F-864E-EBDE7AA54A0D
P2860
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Identification of Kaposi's sar ...... nts receiving highly active an
@en
Identification of Kaposi's sarcoma-associated herpesvirus
@nl
type
label
Identification of Kaposi's sar ...... nts receiving highly active an
@en
Identification of Kaposi's sarcoma-associated herpesvirus
@nl
prefLabel
Identification of Kaposi's sar ...... nts receiving highly active an
@en
Identification of Kaposi's sarcoma-associated herpesvirus
@nl
P2093
P2860
P50
P1433
P1476
Identification of Kaposi's sar ...... active antiretroviral therapy
@en
P2093
Alethea Cope
Brian Gazzard
Chris Boshoff
Dimitra Bourboulia
Frances Gotch
Peter Hayes
Robin Weiss
Vincent Calvez
P2860
P304
P356
10.1128/JVI.76.6.2634-2640.2002
P407
P577
2002-03-01T00:00:00Z